Witte Jan De
President & CEO at Integra LifeSciences Holdings Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Integra LifeSciences Holdings Corporation, 3 years.
Integra LifeSciences Holdings Corporation
Director · President & CEO
ResMed Inc.
Director
Chief executive roles
Integra LifeSciences Holdings Corporation
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2024 | ResMed Inc. | Open-market sale | −360 | $218.29 | $78,584 |
| Mar 11, 2024 | Integra LifeSciences Holdings Corporation | Option exercise | +205 | — | — |
| Mar 11, 2024 | Integra LifeSciences Holdings Corporation | Shares withheld for tax | −205 | $36.22 | $7,425 |
| Mar 10, 2024 | Integra LifeSciences Holdings Corporation | Option exercise | +346 | — | — |
| Mar 10, 2024 | Integra LifeSciences Holdings Corporation | Shares withheld for tax | −346 | $36.73 | $12,709 |
| Jan 18, 2024 | Integra LifeSciences Holdings Corporation | Option exercise | +597 | — | — |
| Jan 18, 2024 | Integra LifeSciences Holdings Corporation | Shares withheld for tax | −597 | $42.39 | $25,307 |
| Nov 16, 2023 | ResMed Inc. | Grant or award | +1,768 | — | — |
| Nov 1, 2023 | Integra LifeSciences Holdings Corporation | Option exercise | +9,814 | — | — |
| Nov 1, 2023 | Integra LifeSciences Holdings Corporation | Shares withheld for tax | −4,262 | $36.85 | $157,055 |
| Jun 1, 2023 | Integra LifeSciences Holdings Corporation | Open-market purchase | +7,792 | $38.50 | $299,992 |
| Mar 11, 2023 | Integra LifeSciences Holdings Corporation | Shares withheld for tax | −3,842 | $52.87 | $203,127 |
| Feb 13, 2023 | Integra LifeSciences Holdings Corporation | Grant or award | +8,848 | — | — |
| Jan 18, 2023 | Integra LifeSciences Holdings Corporation | Option exercise | +431 | — | — |
| Jan 18, 2023 | Integra LifeSciences Holdings Corporation | Shares withheld for tax | −431 | $54.78 | $23,610 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.